-David R Clemmons Researcher Activity Profile

Research Author Detailed Information 

David R Clemmons Publication Rate By Year

David R Clemmons has published 1 paper(s) in 1998, 7 paper(s) in 2007, 1 paper(s) in 2008, for a total of 9 research publications in total.

David R Dr Clemmons Author Information

LAST NAME: clemmons

FIRST NAME: David R

INITIALS: dr

AFFILIATION:

Papers

David R Clemmons's Publication Record

1. Hyperglycemia alters the responsiveness of smooth muscle cells to insulin-like growth factor-I. Year Published: 2007
Department of Medicine, University of North Carolina, Chapel Hill, North Carolina 27599-7170, USA. laura_maile@med.unc.edu
2. Protease-resistant form of insulin-like growth factor-binding protein 5 is an inhibitor of insulin-like growth factor-I actions on porcine smooth muscle cells in culture. Year Published: 1998
Department of Medicine, University of North Carolina School of Medicine, Chapel Hill 27599-7170, USA.
3. Value of insulin-like growth factor system markers in the assessment of growth hormone status. Year Published: 2007
Division of Endocrinology, University of North Carolina School of Medicine, University of North Carolina, CB #7170, 8024 Burnett-Womack, Chapel Hill, NC 27599, USA. endo@med.unc.edu
4. IGF-I assays: current assay methodologies and their limitations. Year Published: 2007
CB# 7170, 8024 Burnett-Womack, Division of Endocrinology, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599-7170, USA, endo@med.unc.edu.
5. Protease-resistant insulin-like growth factor (IGF)-binding protein-4 inhibits IGF-I actions and neointimal expansion in a porcine model of neointimal hyperplasia. Year Published: 2007
Division of Endocrinology, University of North Carolina at Chapel Hill, 8024 Burnett-Womack, Chapel Hill, NC 27599-7170, USA.
6. Expression of the human beta3 integrin subunit in mouse smooth muscle cells enhances IGF-I-stimulated signaling and proliferation. Year Published: 2007
Department of Medicine, University of North Carolina, School of Medicine, Chapel Hill, North Carolina, USA.
7. Expression of the human beta3 integrin subunit in mouse smooth muscle cells enhances IGF-I-stimulated signaling and proliferation. Year Published: 2007
Department of Medicine, University of North Carolina, School of Medicine, Chapel Hill, North Carolina, USA.
8. Long-acting forms of growth hormone-releasing hormone and growth hormone: effects in normal volunteers and adults with growth hormone deficiency. Year Published: 2008
School of Medicine, University of North Carolina, Chapel Hill, NC 27599, USA. endo@med.unc.edu
9. IGF-I assays: current assay methodologies and their limitations. Year Published: 2007
CB# 7170, 8024 Burnett-Womack, Division of Endocrinology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7170, USA. endo@med.unc.edu